Baldo Scassellati Sforzolini

Statistics

Publications

Citations

572

H-Index

Active since

2000

Affiliations

University of California San Diego(Current)

Bausch Health (United States)

Baldo Scassellati Sforzolini is an author at University of California San Diego specializing in medicine, ophthalmology, and intraocular pressure management.

Publications per year

2000–2023

Publications

A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study

Robert N. Weinreb, Tuyen Ong, Baldo Scassellati Sforzolini et al. · British Journal of Ophthalmology · 2014 · 171 citations · Full text

Medicine, Ophthalmology, Pharmacology +17

Latanoprostene Bunod 0.024% versus Timolol Maleate 0.5% in Subjects with Open-Angle Glaucoma or Ocular Hypertension

Robert N. Weinreb, Baldo Scassellati Sforzolini, Jason L. Vittitow et al. · Ophthalmology · 2016 · 128 citations · Full text

Medicine, Ophthalmology, Pharmacology +16

Comparison of Latanoprostene Bunod 0.024% and Timolol Maleate 0.5% in Open-Angle Glaucoma or Ocular Hypertension: The LUNAR Study

Felipe A. Medeiros, Keith R. Martin, James H. Peace et al. · American Journal of Ophthalmology · 2016 · 109 citations · Full text

Medicine, Ophthalmology, Pharmacology +15

Efficacy of Latanoprostene Bunod 0.024% Compared With Timolol 0.5% in Lowering Intraocular Pressure Over 24 Hours

John H.K. Liu, J. Rigby Slight, Jason L. Vittitow et al. · American Journal of Ophthalmology · 2016 · 73 citations · Full text

Medicine, Ophthalmology, Pharmacology +14

Evaluation of the Effect of Latanoprostene Bunod Ophthalmic Solution, 0.024% in Lowering Intraocular Pressure over 24 h in Healthy Japanese Subjects

Makoto Araie, Baldo Scassellati Sforzolini, Jason L. Vittitow et al. · Advances in Therapy · 2015 · 49 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

1–5 of 7